Considerations for defining medication exposure when analyzing real‐world data
Saved in:
Published in: | Pharmacoepidemiology and drug safety Vol. 32; no. 8; pp. 933 - 937 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chichester, UK
John Wiley & Sons, Inc
01-08-2023
Wiley Subscription Services, Inc |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | Lin, Nancy D. Lasky, Tamar Clary, Alecia Chokkalingam, Anand Rodriguez‐Watson, Carla Reynolds, Matthew W. |
---|---|
Author_xml | – sequence: 1 givenname: Alecia orcidid: 0000-0002-7774-9808 surname: Clary fullname: Clary, Alecia email: aclary@reaganudall.org organization: The Reagan‐Udall Foundation for the FDA – sequence: 2 givenname: Nancy D. surname: Lin fullname: Lin, Nancy D. organization: IQVIA Real World Solutions – sequence: 3 givenname: Tamar orcidid: 0000-0003-4104-394X surname: Lasky fullname: Lasky, Tamar organization: The United States Food and Drug Administration, Office of Data, Analytics, & Research, Office of the Commissioner – sequence: 4 givenname: Matthew W. surname: Reynolds fullname: Reynolds, Matthew W. organization: IQVIA Real‐World Solutions – sequence: 5 givenname: Anand surname: Chokkalingam fullname: Chokkalingam, Anand organization: Gilead Sciences – sequence: 6 givenname: Carla surname: Rodriguez‐Watson fullname: Rodriguez‐Watson, Carla organization: The Reagan‐Udall Foundation for the FDA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36929112$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kMtKw0AUQAep2FYFv0ACbtyk3nk2s5T6hIIFdR0mk4lOSTN1pqHWlZ_gN_olJm1VEFzdC_dw4J4-6lSuMggdYRhgAHI2z8OAC0x3UA-DlDHmfNhpd07jhAvZRf0QpgDNTbI91KVCEokx6aHJyFXB5sarhW22qHA-yk1hK1s9RTOTW70-ROZ17kLtTbR8NlWkKlWu3lrEG1V-vn8snS_zKFcLdYB2C1UGc7id--jx6vJhdBOP765vR-fjWFPGaKy1VDIrMqYKmQicyMIwoFqTAsQwIxQEEMphyPJM4gwE4wxyTTA3mDOugO6j04137t1LbcIindmgTVmqyrg6pCQBKoVglDToyR906mrfvNBSlCaCU6C_Qu1dCN4U6dzbmfKrFEPaVk6bymlbuUGPt8I6axr9gN9ZGyDeAEtbmtW_onRycb8WfgHDiIfI |
Cites_doi | 10.1177/1474651411422825 10.1007/s10916-009-9278-5 10.1093/jamia/ocv202 10.1002/pds.4372 10.1093/jamia/ocv054 10.1002/pds.5372 10.1001/jamanetworkopen.2022.50423 10.1016/j.jval.2017.08.3019 10.1016/j.jclinepi.2009.07.001 |
ContentType | Journal Article |
Copyright | 2023 Reagan‐Udall Foundation for the FDA. published by John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 Reagan‐Udall Foundation for the FDA. published by John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA. – notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P WIN NPM AAYXX CITATION 7TK K9. 7X8 |
DOI | 10.1002/pds.5613 |
DatabaseName | Wiley-Blackwell Titles (Open access) Wiley Online Library Free Content PubMed CrossRef Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1099-1557 |
EndPage | 937 |
ExternalDocumentID | 10_1002_pds_5613 36929112 PDS5613 |
Genre | commentary Journal Article |
GrantInformation_xml | – fundername: Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) – fundername: FDA HHS grantid: U01 FD007223 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA GWYGA H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES M6Q MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V8K W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WWP WXI WXSBR XG1 XV2 YCJ ZZTAW ~IA ~WT NPM AAMNL AAYXX CITATION 7TK K9. 7X8 |
ID | FETCH-LOGICAL-c3443-cc9a9bfb4af986189fe403cc2f067b23060235074db91b064540dc215e1545a03 |
IEDL.DBID | 33P |
ISSN | 1053-8569 |
IngestDate | Sat Aug 17 00:54:39 EDT 2024 Thu Oct 10 17:42:31 EDT 2024 Thu Nov 21 21:40:15 EST 2024 Sat Sep 28 08:10:07 EDT 2024 Sat Aug 24 00:53:40 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
License | Attribution-NonCommercial |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3443-cc9a9bfb4af986189fe403cc2f067b23060235074db91b064540dc215e1545a03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4104-394X 0000-0002-7774-9808 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpds.5613 |
PMID | 36929112 |
PQID | 2833865303 |
PQPubID | 105383 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_2803966432 proquest_journals_2833865303 crossref_primary_10_1002_pds_5613 pubmed_primary_36929112 wiley_primary_10_1002_pds_5613_PDS5613 |
PublicationCentury | 2000 |
PublicationDate | August 2023 2023-Aug 2023-08-00 20230801 |
PublicationDateYYYYMMDD | 2023-08-01 |
PublicationDate_xml | – month: 08 year: 2023 text: August 2023 |
PublicationDecade | 2020 |
PublicationPlace | Chichester, UK |
PublicationPlace_xml | – name: Chichester, UK – name: England – name: Bethesda |
PublicationTitle | Pharmacoepidemiology and drug safety |
PublicationTitleAlternate | Pharmacoepidemiol Drug Saf |
PublicationYear | 2023 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2010; 34 2017; 20 2011; 11 2018; k3532 2022; 31 2022 2023; 6 2021; m4856 2018; 27 2010; 63 2016; 23 2015; 22 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_2_1 e_1_2_7_15_1 Wang SV (e_1_2_7_12_1) 2021; 4856 e_1_2_7_13_1 e_1_2_7_11_1 e_1_2_7_10_1 Langan SM (e_1_2_7_14_1) 2018; 3532 |
References_xml | – volume: 6 year: 2023 article-title: Trends and characteristics of potentially preventable emergency department visits among patients with cancer in the US publication-title: JAMA Netw Open Am Med Assoc – volume: 27 start-page: 148 year: 2018 end-page: 160 article-title: Methods for time‐varying exposure related problems in pharmacoepidemiology: an overview publication-title: Pharmacoepidemiol Drug Saf – volume: 22 start-page: 957 year: 2015 end-page: 961 article-title: An algorithm to identify medication nonpersistence using electronic pharmacy databases publication-title: J Am Med Inform Assoc – volume: 23 year: 2016 article-title: PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability publication-title: J Am Med Inform Assoc – volume: 63 start-page: 422 year: 2010 end-page: 427 article-title: Construction of drug treatment episodes from drug‐dispensing histories is influenced by the gap length publication-title: J Clin Epidemiol – volume: m4856 start-page: 372 year: 2021 article-title: STaRT‐RWE: structured template for planning and reporting on the implementation of real world evidence studies publication-title: Br Med J – volume: k3532 start-page: 363 year: 2018 article-title: The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD‐PE) publication-title: Br Med J – volume: 11 start-page: 304 year: 2011 end-page: 307 article-title: The European network of Centres for pharmacoepidemiology and pharmacovigilance: application to diabetes and vascular disease publication-title: Br J Diab Vasc Dis – volume: 20 start-page: 1003 year: 2017 end-page: 1008 article-title: Good practices for real‐world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR‐ISPE special task force on real‐world evidence in health care decision making publication-title: Value Health – volume: 31 start-page: 13 year: 2022 end-page: 21 article-title: A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies publication-title: Pharmacoepidemiol Drug Saf – year: 2022 – volume: 34 start-page: 651 year: 2010 end-page: 657 article-title: Achieving standardized medication data in clinical research studies: two approaches and applications for implementing RxNorm publication-title: J Med Syst – ident: e_1_2_7_5_1 – ident: e_1_2_7_15_1 doi: 10.1177/1474651411422825 – ident: e_1_2_7_2_1 doi: 10.1007/s10916-009-9278-5 – ident: e_1_2_7_3_1 doi: 10.1093/jamia/ocv202 – ident: e_1_2_7_9_1 doi: 10.1002/pds.4372 – volume: 3532 start-page: 363 year: 2018 ident: e_1_2_7_14_1 article-title: The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD‐PE) publication-title: Br Med J contributor: fullname: Langan SM – ident: e_1_2_7_11_1 doi: 10.1093/jamia/ocv054 – ident: e_1_2_7_6_1 – ident: e_1_2_7_8_1 doi: 10.1002/pds.5372 – ident: e_1_2_7_4_1 – ident: e_1_2_7_7_1 doi: 10.1001/jamanetworkopen.2022.50423 – volume: 4856 start-page: 372 year: 2021 ident: e_1_2_7_12_1 article-title: STaRT‐RWE: structured template for planning and reporting on the implementation of real world evidence studies publication-title: Br Med J contributor: fullname: Wang SV – ident: e_1_2_7_13_1 doi: 10.1016/j.jval.2017.08.3019 – ident: e_1_2_7_10_1 doi: 10.1016/j.jclinepi.2009.07.001 |
SSID | ssj0009994 |
Score | 2.4254115 |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 933 |
Title | Considerations for defining medication exposure when analyzing real‐world data |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpds.5613 https://www.ncbi.nlm.nih.gov/pubmed/36929112 https://www.proquest.com/docview/2833865303 https://search.proquest.com/docview/2803966432 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV27TsMwFLWgEwvvR6AgI6FODU3jJLXZELTqhCK1SGyR7ThiQGlFqKBMfALfyJdwr9M0qhASElMGO3Hk6-tz_LjnEnKRam6E6hpwJMncgGWhKwGmXQPQIINQA-JgNPJw1Lt74Ld9lMm5qmJhSn2I5YYbeoadr9HBpSo6tWjoNC0ukf3C9AuLBBu9weJab1fYHIjAHpjLw0hUurOe36leXEWiH_Ryla1auBls_edHt8nmgmTS63JU7JA1k--SVlyqVM_bdFwHXRVt2qJxrV893yNxlcSz3MyjQGtpajKbSYLas3hbQM3bdIL7i_T10eRUorrJO1YBGvr09fFptVgp3kDdJ_eD_vhm6C4SL7iaBQFztRZSqEwFMhM86nKRmcBjWvsZYJvCRQuq5AD5SJXoKlS8C7xUA3kwSMikxw5II5_k5ohQ7qWekkYBz4Ii7fNIsVBpr-fzTAvOHXJeGSGZlvoaSamk7CfQcQl2nEOalXWShYcVCdAiTFcKCAyfWBaDb-CBh8zNZIZ1PAbLuYD5DjksrbpshEVADIFsOqRljfdr60l8O8Ln8V8rnpANzElf3hJsksbL88yckvUinZ3ZMfoNUp3pYQ |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JT_MwEB2xHODC-gFlNRLqiXyksRtscUIsKmJRJIrELbIdRxxQWlEqlhM_gd_IL2HGaVohhITEKQc7ceTx5L2MPW8AdjIrnTINh46keSB43gw0wnTgEBq0aFpEHMpGbl3vX93K4xOSyTmocmFKfYhhwI08w3-vycEpIL03Ug3tZr3_RH_HYVLEuA4pf4MnI8Vd5asgIn_ggWzGqlKeDaO96s6vWPSNYH7lqx5wTmf_9KpzMDPgmeywXBjzMOaKBagnpVD1yy5rj_KueruszpKRhPXLIiRVHc8ynseQ2bLM5b6YBPPb8b6Bueduh0KM7OnOFUyTwMkrdUEmev_x9u7lWBkdQv0HN6cn7aNWMKi9EFguBA-sVVqZ3AidKxk3pMqdCLm1UY7wZui_hYRykH9kRjUMid6JMLPIHxxxMh3yJZgoOoVbASbDLDTaGaRa2GQjGRveNDbcj2RulZQ12K6skHZLiY20FFOOUpy4lCauBuuVedKBk_VSZEZUsRRBGB8xbEb3oD0PXbhOn_qEHP_oBI9qsFyadTgIj5EbIt-sQd1b78fR0-T4mq6rv-24BVOt9uVFenF2db4G01Sivjw0uA4Tjw99twHjvay_6RfsJxAN7Yk |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1bS8MwFMcPXkB88X6Z1wiyJ6tdk83EN3EORRkFFXwrSZrig3TDObw8-RH8jH4Sz0nXjSGC4FMfkjYlJ6fn11z-B2A_tdIpU3PoSJoHgmf1QGOYDhyGBi3qFiMOnUa-uDlu38vmOcnknJRnYQp9iOGEG3mG_16Tg3fT7GgkGtpNe4dEv5MwLZDCSTef83gkuKt8EkTEBx7IekOVwrNhdFTeOR6KfvDlOK76eNOa_8-bLsDcgDLZaTEsFmHC5UtQjQuZ6rcDdjs6ddU7YFUWjwSs35YhLrN4FrN5DLmWpS7zqSSYX4z3Bcy9djs0wcheHlzONMmbvFMV5NDHr49PL8bKaAvqCty1zm_PLoJB5oXAciF4YK3SymRG6EzJRk2qzImQWxtlGNwM_bWQTA7SR2pUzZDknQhTi_TgiMh0yFdhKu_kbh2YDNPQaGcQtLDIRrJheN3Y8DiSmVVSVmCvNELSLQQ2kkJKOUqw4xLquApsldZJBi7WS5CLKF8phmB8xLAYnYNWPHTuOn2qE3L8nxM8qsBaYdVhI7yBZIi0WYGqN96vrSdx84auG3-tuAszcbOVXF-2rzZhlvLTFzsGt2Dq-anvtmGyl_Z3_HD9BkEQ7C8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Considerations+for+defining+medication+exposure+when+analyzing+real%E2%80%90world+data&rft.jtitle=Pharmacoepidemiology+and+drug+safety&rft.au=Clary%2C+Alecia&rft.au=Lin%2C+Nancy+D.&rft.au=Lasky%2C+Tamar&rft.au=Reynolds%2C+Matthew+W.&rft.date=2023-08-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1053-8569&rft.eissn=1099-1557&rft.volume=32&rft.issue=8&rft.spage=933&rft.epage=937&rft_id=info:doi/10.1002%2Fpds.5613&rft.externalDBID=10.1002%252Fpds.5613&rft.externalDocID=PDS5613 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-8569&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-8569&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-8569&client=summon |